Despite emerging evidence that preemptive transplantation is the best treatment modality for patients reaching end-stage renal disease (ESRD), it is underutilized. Nephrologists' views on preemptive transplantation are explored herein.
Department of Pharmaceutical Health Services Research, School of Pharmacy, University of Maryland, Baltimore,Maryland 21201, USA. fpradel@rx.umaryland.edu